Ambey Laboratories Limited — Others, 28-07-2025: Shareholders meeting

Ambey Laboratories' EOGM saw shareholders approve key strategic proposals. Members voted to increase the company's authorized share capital and amend its Articles of Association. Additionally, a significant preferential issue of up to 1.08 Cr fully convertible warrants to promoter and non-promoter categories was approved. All resolutions passed with 100% assent from polled votes, signaling robust shareholder support. This strategic move strengthens the company's capital base and enables future growth initiatives through new funding.